Patents by Inventor Richard Clark Kaufman

Richard Clark Kaufman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of Anti-Inflammatory Nutraceuticals
    Publication number: 20240074985
    Abstract: Novel process and products thereby emplace NSAIDS within nanodelivery vehicles for various indications in mammals, including humans.
    Type: Application
    Filed: July 24, 2023
    Publication date: March 7, 2024
    Inventor: Richard Clark Kaufman
  • Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of NSAIDS
    Patent number: 11707436
    Abstract: Novel process and products thereby emplace NSAIDS within nanodelivery vehicles for various indications in mammals, including humans.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: July 25, 2023
    Inventor: Richard Clark Kaufman
  • LIPID NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF CANNABINOIDS IN STANDARDIZED PRECISION-METERED DOSAGE FORMS
    Publication number: 20220304938
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Application
    Filed: June 16, 2022
    Publication date: September 29, 2022
    Inventor: Richard Clark Kaufman
  • DRUG DELIVERY COMPOSITION AND A METHOD OF ADMINISTERING THE DRUG
    Publication number: 20220202844
    Abstract: A drug delivery system that includes nicotinamide adenine dinucleotide or a derivative or a precursor thereof, and a chemical drug delivery enhancer composition. The drug delivery system enhances the delivery of the nicotinamide adenine dinucleotide or derivatives or precursors thereof through different delivery routes.
    Type: Application
    Filed: January 3, 2022
    Publication date: June 30, 2022
    Inventor: Richard Clark Kaufman
  • LIPID NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF CANNABINOIDS IN STANDARDIZED PRECISION-METERED DOSAGE FORMS
    Publication number: 20200237679
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Application
    Filed: March 23, 2020
    Publication date: July 30, 2020
    Inventor: Richard Clark Kaufman
  • Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
    Patent number: 10596124
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: March 24, 2020
    Assignee: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • LIPID NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF CANNABINOIDS IN STANDARDIZED PRECISION-METERED DOSAGE FORMS
    Publication number: 20180296493
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Application
    Filed: June 21, 2018
    Publication date: October 18, 2018
    Inventor: Richard Clark Kaufman
  • Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms
    Patent number: 10028919
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: July 24, 2018
    Assignee: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
    Patent number: 9925149
    Abstract: Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: March 27, 2018
    Assignee: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • Methods of Treating Inflammatory Disorders and Global Inflammation with Compositions Comprising Phospholipid Nanoparticle Encapsulations of NSAIDS
    Publication number: 20180055782
    Abstract: Novel process and products thereby emplace NSAIDS within nanodelivery vehicles for various indications in mammals, including humans.
    Type: Application
    Filed: December 14, 2015
    Publication date: March 1, 2018
    Inventor: Richard Clark Kaufman
  • LIPID NANOPARTICLE COMPOSITIONS AND METHODS AS CARRIERS OF CANNABINOIDS IN STANDARDIZED PRECISION-METERED DOSAGE FORMS
    Publication number: 20170000744
    Abstract: This disclosure teaches phospholipid nanoparticle compositions of cannabinoids formed from phospholipids and simpler lipids in an unfired sequential process that encapsulate a high concentration of cannabinoids, and create standardized precision-metered dosage forms of cannabinoids; yielding an increase cannabinoid transport across hydrophobic mucosa; increase the bioavailability of the cannabinoid 2-fold to 8-fold, decrease the dose of cannabinoids 2-fold to 8-fold less than an amount of cannabinoids needed to illicit the same therapeutic effect compared to raw and non-encapsulated cannabinoids; where the nanoparticle dynamic structure reduces the adverse effects of cannabinoids; and enable safe more efficacious cannabinoid therapy.
    Type: Application
    Filed: June 4, 2015
    Publication date: January 5, 2017
    Applicant: NANOSPHERE HEALTH SCIENCES, LLC
    Inventor: Richard Clark Kaufman
  • Nanoparticle Compositions and Methods as Carriers of Nutraceutical Factors Across Cell Membranes and Biological Barriers
    Publication number: 20160263047
    Abstract: Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.
    Type: Application
    Filed: October 14, 2014
    Publication date: September 15, 2016
    Applicant: Nanaspehre Health Sciences, LLC
    Inventor: Richard Clark Kaufman